Earnings call transcript: CME Group tops Q3 2026 estimates as revenue hits record

CME Group reported Q3 2026 earnings of $3.02 per share, beating estimates by $0.04, with revenue of $1.74B, up 13% YoY. Market data revenue rose 20% to $243M, and average daily volume hit a record 29.4M contracts. The stock slipped 1% in premarket trading to $292.37. Management expects record full-year volume, 12% ahead of 2025.

Original reporting
Published Oct 21, 2026, 1:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 2:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Neutral
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on uk.investing.com
Decision brief

The 30-second read

$CMENeutralMed
01

Why it matters

Earnings beat was modest; pre‑market price fell 1%, indicating limited immediate upside but confirming defensive business model.

02

Market read

CME's earnings reinforce its defensive positioning but the modest beat may keep the stock under pressure in the short term.

03

What to watch

Regulatory delays on Compute Futures and pricing changes could limit near‑term upside despite strong volume growth.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

CME Group is a leading derivatives exchange operator with diversified revenue across asset classes.

Company-level read

Ticker impact

$CMENeutralHigh confidence
Context

CME Group reported Q3 2026 earnings beating estimates with record revenue, but shares slipped 1% pre‑market.

Expected impact

likely modest pressure as the market prices in the modest beat and valuation concerns

Evidence & confidence

The beat was small (EPS +1.34%, revenue +1.75%) and the stock already fell 1% pre‑market, suggesting limited upside and possible short‑term weakness.

Market effects

Strong record revenue and volume may reinforce bullish views on the broader exchange and market‑data sector.

U.S. equities may see slight pullback in financials as CME shares dip.

CME's global footprint means the earnings beat could modestly support risk‑management demand worldwide.

Counterpoint

The modest beat and record revenue could be a buying opportunity if the market over‑reacts to the 1% dip.

Key entities

  • CME Group Inc.

    U.S.-listed exchange operator (ticker CME) reporting Q3 2026 results.

  • Terry Duffy

    Chairman and CEO of CME Group, provided commentary on volatility backdrop.

Related articles

$CMEMed

CME Nears Uranium Storage Deal for Physical Futures Contract

CME Group is nearing a deal with ConverDyn (a joint venture between Solstice Advanced Materials and General Atomics) to store uranium for a physical futures contract. The deal, expected to close by year-end, would involve Solstice managing inventories at its Illinois facility. This follows rising uranium demand and prices, with the spot price up over 10% this year.

$CMEMed

Nuclear Revival Spurs CME to Move Ahead on Physical Uranium Contracts

CME Group Inc. is developing a new uranium futures contract backed by physical supplies, partnering with ConverDyn (a joint venture between Solstice Advanced Materials Inc. and General Atomics) for storage. The contract aims to address surging uranium demand amid a global nuclear power revival. Uranium spot prices have tripled over six years, reaching over $90 per pound. The deal is expected to finalize by year-end, pending legal review.

$CMEMed

CME Group is said to plan physically backed uranium futures contract

CME Group is planning to launch a physically backed uranium futures contract, according to Bloomberg. The exchange is close to an agreement with ConverDyn for uranium storage, which could be finalized by year-end. The contract would allow investors to trade uranium backed by physical inventories, potentially improving price discovery and risk management.

$CMEMed

Rate Trading Rose in October and a Fed Governor Leans Toward Backing a December Hike

U.S. stocks fell and 10-year Treasury yield rose on Tuesday after October CPI data showed a 0.4% increase. Fed Governor Waller leaned toward a December rate hike. CME Group, ICE, Tradeweb, Nasdaq, and BGC Group reported increased trading volumes in interest rate products. CME Group's October ADV hit 30 million contracts, up 15% YoY, with interest rate ADV up 28%. ICE reported 14% YoY increase in total October ADV and 40% in interest rates ADV.